Use of an amylin antagonist for the manufacture of a medicament for the treatment of obesity and essential hypertension and related disorders

摘要

The administration of antagonists and blockers of amylin or CGRP or both for the treatment of obesity and essential hypertension and associated lipid disorders and atherosclerosis.